165 related articles for article (PubMed ID: 34577145)
1. In Vitro Phenotypic Activity and In Silico Analysis of Natural Products from Brazilian Biodiversity on
Peres RB; Fiuza LFA; da Silva PB; Batista MM; Camillo FDC; Marques AM; de C Brito L; Figueiredo MR; Soeiro MNC
Molecules; 2021 Sep; 26(18):. PubMed ID: 34577145
[TBL] [Abstract][Full Text] [Related]
2. Antiparasitic Activity of
Peres RB; Batista MM; Bérenger ALR; Camillo FDC; Figueiredo MR; Soeiro MNC
Pharmaceutics; 2023 May; 15(5):. PubMed ID: 37242777
[TBL] [Abstract][Full Text] [Related]
3. In Vitro and In Vivo Trypanosomicidal Action of Novel Arylimidamides against Trypanosoma cruzi.
Guedes-da-Silva FH; Batista DG; Meuser MB; Demarque KC; Fulco TO; Araújo JS; Da Silva PB; Da Silva CF; Patrick DA; Bakunova SM; Bakunov SA; Tidwell RR; Oliveira GM; Britto C; Moreira OC; Soeiro MN
Antimicrob Agents Chemother; 2016 Apr; 60(4):2425-34. PubMed ID: 26856830
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of 2-hydroxy-3-phenylsulfanylmethyl-[1,4]-naphthoquinone derivatives against different Trypanosoma cruzi discrete type units: Identification of a promising hit compound.
Lara LS; Moreira CS; Calvet CM; Lechuga GC; Souza RS; Bourguignon SC; Ferreira VF; Rocha D; Pereira MCS
Eur J Med Chem; 2018 Jan; 144():572-581. PubMed ID: 29289882
[TBL] [Abstract][Full Text] [Related]
5. Identification of Pyrazolo[3,4-e][1,4]thiazepin based CYP51 inhibitors as potential Chagas disease therapeutic alternative: In vitro and in vivo evaluation, binding mode prediction and SAR exploration.
Ferreira de Almeida Fiuza L; Peres RB; Simões-Silva MR; da Silva PB; Batista DDGJ; da Silva CF; Nefertiti Silva da Gama A; Krishna Reddy TR; Soeiro MNC
Eur J Med Chem; 2018 Apr; 149():257-268. PubMed ID: 29501946
[TBL] [Abstract][Full Text] [Related]
6. Leishmanicidal Activity of Withanolides from
Lima SCM; Pacheco JDS; Marques AM; Veltri ERP; Almeida-Lafetá RC; Figueiredo MR; Kaplan MAC; Torres-Santos EC
Molecules; 2018 Nov; 23(12):. PubMed ID: 30513673
[TBL] [Abstract][Full Text] [Related]
7.
Nefertiti ASG; Batista MM; Da Silva PB; Batista DGJ; Da Silva CF; Peres RB; Torres-Santos EC; Cunha-Junior EF; Holt E; Boykin DW; Brun R; Wenzler T; Soeiro MNC
Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29203485
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo antiparasitic activity of Physalis angulata L. concentrated ethanolic extract against Trypanosoma cruzi.
Meira CS; Guimarães ET; Dos Santos JA; Moreira DR; Nogueira RC; Tomassini TC; Ribeiro IM; de Souza CV; Ribeiro Dos Santos R; Soares MB
Phytomedicine; 2015 Oct; 22(11):969-74. PubMed ID: 26407938
[TBL] [Abstract][Full Text] [Related]
9. Phenotypic Screening In Vitro of Novel Aromatic Amidines against Trypanosoma cruzi.
Simões-Silva MR; Nefertiti AS; De Araújo JS; Batista MM; Da Silva PB; Bahia MT; Menna-Barreto RS; Pavão BP; Green J; Farahat AA; Kumar A; Boykin DW; Soeiro MN
Antimicrob Agents Chemother; 2016 Aug; 60(8):4701-7. PubMed ID: 27216059
[TBL] [Abstract][Full Text] [Related]
10. Phenotypic evaluation and in silico ADMET properties of novel arylimidamides in acute mouse models of
da Silva CF; Batista DDGJ; de Araújo JS; Cunha-Junior EF; Stephens CE; Banerjee M; Farahat AA; Akay S; Fisher MK; Boykin DW; Soeiro MNC
Drug Des Devel Ther; 2017; 11():1095-1105. PubMed ID: 28435221
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, structure-activity relationship and trypanocidal activity of pyrazole-imidazoline and new pyrazole-tetrahydropyrimidine hybrids as promising chemotherapeutic agents for Chagas disease.
Monteiro ME; Lechuga G; Lara LS; Souto BA; Viganó MG; Bourguignon SC; Calvet CM; Oliveira FOR; Alves CR; Souza-Silva F; Santos MS; Pereira MCS
Eur J Med Chem; 2019 Nov; 182():111610. PubMed ID: 31434040
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the anti-Trypanosoma cruzi activity in vitro and in vivo of silibinin and silibinin in association to benznidazole.
Torchelsen FKVDS; Silva TM; Milagre MM; Silva RR; Reis LES; Branquinho RT; Silva GN; de Lana M
Parasitol Res; 2021 Apr; 120(4):1511-1517. PubMed ID: 33236174
[TBL] [Abstract][Full Text] [Related]
13. Drug repurposing strategy against Trypanosoma cruzi infection: In vitro and in vivo assessment of the activity of metronidazole in mono- and combined therapy.
Simões-Silva MR; De Araújo JS; Oliveira GM; Demarque KC; Peres RB; D'Almeida-Melo I; Batista DGJ; Da Silva CF; Cardoso-Santos C; Da Silva PB; Batista MM; Bahia MT; Soeiro MNC
Biochem Pharmacol; 2017 Dec; 145():46-53. PubMed ID: 28870526
[TBL] [Abstract][Full Text] [Related]
14. Quantum mechanical, molecular docking, molecular dynamics, ADMET and antiproliferative activity on
Geysillene Castro Matos M; da Silva LP; Wagner Queiroz Almeida-Neto F; Machado Marinho E; Róseo Paula Pessoa Bezerra de Menezes R; Lima Sampaio T; Nunes da Rocha M; Rodrigues Ribeiro L; Paula Magalhaes E; Rodrigues Teixeira AM; Dos Santos HS; Marinho ES; de Lima-Neto P; Costa Martins AM; Monteiro NKV; Machado Marinho M
Phys Chem Chem Phys; 2022 Feb; 24(8):5052-5069. PubMed ID: 35144275
[TBL] [Abstract][Full Text] [Related]
15. Unlocking the in vitro anti-Trypanosoma cruzi activity of halophyte plants from the southern Portugal.
Oliveira M; Sales Junior PA; Rodrigues MJ; DellaGreca M; Barreira L; Murta SM; Romanha AJ; Custódio L
Asian Pac J Trop Med; 2016 Aug; 9(8):735-41. PubMed ID: 27569881
[TBL] [Abstract][Full Text] [Related]
16. Germacranolide-type sesquiterpene lactones from Smallanthus sonchifolius with promising activity against Leishmania mexicana and Trypanosoma cruzi.
Ulloa JL; Spina R; Casasco A; Petray PB; Martino V; Sosa MA; Frank FM; Muschietti LV
Parasit Vectors; 2017 Nov; 10(1):567. PubMed ID: 29132413
[TBL] [Abstract][Full Text] [Related]
17. Repurposing Strategy of Atorvastatin against Trypanosoma cruzi:
Araujo-Lima CF; Peres RB; Silva PB; Batista MM; Aiub CAF; Felzenszwalb I; Soeiro MNC
Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29987140
[TBL] [Abstract][Full Text] [Related]
18. Structural design, synthesis and pharmacological evaluation of thiazoles against Trypanosoma cruzi.
de Oliveira Filho GB; Cardoso MVO; Espíndola JWP; Oliveira E Silva DA; Ferreira RS; Coelho PL; Anjos PSD; Santos ES; Meira CS; Moreira DRM; Soares MBP; Leite ACL
Eur J Med Chem; 2017 Dec; 141():346-361. PubMed ID: 29031078
[TBL] [Abstract][Full Text] [Related]
19. Activity in vitro and in vivo against Trypanosoma cruzi of a furofuran lignan isolated from Piper jericoense.
García-Huertas P; Olmo F; Sánchez-Moreno M; Dominguez J; Chahboun R; Triana-Chávez O
Exp Parasitol; 2018 Jun; 189():34-42. PubMed ID: 29656102
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo drug combination for the treatment of Trypanosoma cruzi infection: A multivariate approach.
Strauss M; Rodrigues JHS; Lo Presti MS; Bazán PC; Báez AL; Paglini-Oliva P; Nakamura CV; Bustamante JM; Rivarola HW
Exp Parasitol; 2018 Jun; 189():19-27. PubMed ID: 29726395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
